Integration success rates and the preservation of crestal bone will be higher for the experimental device than for the control implants.
In this study patients are randomized to receive either the experimental implant system or the control Nanotite Certain Tapered (standard abutment connection) and assessed for integration success measured by lack of implant mobility and lack of bone loss obtained at various study time points
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
49
New abutment connection implant
Nanotite Certain Tapered (standard abutment connection) implant
UNICOC
Bogotá, Colombia
Cumulative success rate
Crestal bone regression (amount of bone loss measured) and equivalence in integration success (implant mobility)
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.